Navigation Links
Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
Date:9/12/2007

2,124

Current portion of deferred revenue and

advances 131,244 657,541

Current portion of obligation under capital

leases - 18,390

-------------------------------------------------------------------------

Total current liabilities 3,695,642 4,364,068

Deferred revenue and advances 9,885,733 1,596,727

Obligation under capital leases - 30,401

Leasehold inducement 91,456 102,888

Future tax liability - 2,729,422

-------------------------------------------------------------------------

Total liabilities 13,672,831 8,823,506

-------------------------------------------------------------------------

Commitments

Guarantees

Subsequent events

Shareholders' equity

Share capital

Common shares 133,988,318 99,563,853

Contributed surplus 4,487,752 4,469,987

Stock options 1,538,396 774,858

Deficit (89,691,569) (69,504,180)

-------------------------------------------------------------------------

Total shareholders' equity 50,322,897 35,304,518

-------------------------------------------------------------------------

63,995,728 44,128,024

-------------------------------------------------------------------------

-------------------------------------------------------------------------

CONSOLIDATED STATEMENTS OF LOSS AND DEFICIT

Years ended June 30

(in Canadian dollars)

<
'/>"/>
SOURCE Transition Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Mans Transition from Foragers to Agriculturalist Led to Increase in Birth Rates
2. Rocky Transition to the Medicare Drug Program
3. Customized Post Operation Care Offers Patients a Smooth Transition to Patients into the Community
4. Mental Health - NHS Trust Commences Specialist Transition Service
5. Permanent Weight Loss Requires Transition to Healthy Eating
6. VBI Provides Potential Targets to Diabetes Therapeutics
7. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
8. PM announces a new health care order for India
9. Ramdoss Announces Introduction of RCH-II
10. Britain Announces Third Transfusion Related Mad Cow Case
11. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...Research Shows Moms Seek Quality Online Tools , ... , Academy of General Dentistry Creates Comprehen...e-USNewswire/ -- Everyone knows that Moms are th...lds today. So it,s no wonder that, when it comes ... "Mother knows best." But until now, busy Moms we...
(Date:1/7/2009)...teenage boys don,t seem to be as susceptible, stud...Day News) -- Teenage girls who spend more than two... the Web or text-messaging are less likely to be p...Interestingly, boys who were part of the same stud... said lead author Louise Hardy, a postdoctoral fel...
(Date:1/7/2009)...HAT: , The Sixth International Chronic Total Occl...ng state-of-the-art technologies, research finding...hat are essential for interventional cardiologists...oronary occlusions. The conference will include pr... sessions, and numerous thematically organized liv...
(Date:1/7/2009)...ulsbo, WA January 7, 2009 Human calmodulin-like ...g breast, thyroid, prostate, kidney, and skin. The... a highly specific expression. Gaining an understa...al cells and its possible downregulation (or lack ...able marker in early detection of oral cancer. A n...
Breaking Medicine News(10 mins):Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 2Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 3Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 4Health News:KnowYourTeeth.com Launches as the Internet's New Go-To Resource for 'All Things Dental' 5Health News:More 'Screen Time' Linked to Poor Fitness in Girls 2
...wo new drugs on the Pharmaceutical Benefits Scheme...atment from October.// According to Health Minist...vemir and Lantus will be subsidized from October 1...r the next three years. These drugs have several ...
...rina, the American Academy of Pediatrics (AAP) is ...s to prepare// for potential natural and other dis... on children. Children are especially vulnerable ...commends that parents discuss possible disaster pl...
...ut 5 million adult Americans have moderate or seve...according to a Mayo Clinic study// published onlin...usly the main cause of valve diseases and was a ma...ddle of the 20th century, rheumatic fever is not a...
...ia appears to have met with unprecedented success.... of more than 2,000// children aged four to 12. T...ram lighter than those in a control group of child...al weight loss of one kilogram is not much, but he...
Other Medicine News:Health News:AAP Urges Families To Create Emergency Disaster Plans 2Health News:AAP Urges Families To Create Emergency Disaster Plans 3Health News:Valve Disease Study Suggests New Public Health Concern 2Health News:Valve Disease Study Suggests New Public Health Concern 3
(Date:12/17/2008)...f., Dec. 17 PEAK Surgical, Inc., a...tissue dissection system based on a,proprietary t...Drug,Administration (FDA) has granted the company...ystem for cutting and coagulation of soft tissue d...and throat), gynecologic,orthopedic, arthroscopi...
(Date:12/17/2008)...POLIS, France, December 17 /PRNewswire-FirstCall/ ...nounced positive results of a,pre-specified poole...OA) from,the 301, 302 and 303 pivotal phase 3 stu...howed a significant reduction in systolic and dias...proxen 500 mg bid over the whole 13 week,period (...
(Date:12/16/2008)...rs New Link Between Inflammation & Alzheimer,s...swire/ -- The Roskamp Institute today announced th...en inflammation and Alzheimer,s disease and have i...therapeutics for intervention in this disease. Th..., Ph.D., is detailed in the American Chemical Soc...
(Date:12/16/2008)...eutics Technology Provided CML Biomarker Data for ...wire-FirstCall/ -- Synvista Therapeutics, Inc. ( ...blications demonstrating findings from studies tha...ation end product (A.G.E.) called carboxymethyl-ly...cline in renal function and arterial stiffness in ...
Breaking Medicine Technology:PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 2NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 3NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 5Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 3Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 2Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 3Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 4Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 5Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis 32503 1Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis 32503 2Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis 32503 3Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis 32503 4Molecular marker identifies normal stem cells as intestinal tumor source 32500 1Molecular marker identifies normal stem cells as intestinal tumor source 32500 2St Josephs Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians 9709 1St Josephs Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians 9709 2St Josephs Hospital and Medical Center to Utilize Clinical InfoNET System for Physicians 9709 3Cheryl Burke of Dancing with the Stars Joins Forces With Time Life To Create a Brand New Dance Workout DISCO ABS 32497 1Cheryl Burke of Dancing with the Stars Joins Forces With Time Life To Create a Brand New Dance Workout DISCO ABS 32497 2Cheryl Burke of Dancing with the Stars Joins Forces With Time Life To Create a Brand New Dance Workout DISCO ABS 32497 3
... Launches 1,000-Patient Lung Cancer Diversity Stud...- Statistics show,lung cancer is the leading cause... new cases expected to be diagnosed,and 16,700 dea...ng,cancer is the leading cause of cancer death in ...r death in Hispanic women.(ii),Researchers at Eli ...
... showed an overall CBR of 52% which compares favor...CITY, QC, June 04, 2007 /PRNewswire-FirstCall/ - A...company focused on,endocrine therapy and oncology,...ceuticals presented a poster outlining Phase 1 and...er signal,transduction inhibitor compound, for the...
Other Medicine Technology:Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 2Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 3Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 4Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 5Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 6Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 7Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 8Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 9Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 10Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 11AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 2AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 4
...to / MVR knife. 1.1 mm (19G) with a 1.38 mm width ...ca). State-of-the-art manufacturing and quality co...d precise. Sure grip handles have a ridge indicati... fluid tight incision for self-sealing wounds. Gau...
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro
Renu Multiplus preservative free lubricating and rewetting drops soothe and moisturize your eyes while you're wearing soft contact lenses. The gentle preservative free formula is ideal for eyes that
Medicine Products: